Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial The outcome of IF in T-ALL remains poor with current therapy. The lack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results